| AIVCX | RERCX | AIVCX / RERCX | |
| Total Expense Ratio | 1.67 | 1.12 | 149% |
| Annual Report Gross Expense Ratio | 1.68 | 1.12 | 150% |
| Fund Existence | 7 years | 24 years | - |
| Gain YTD | 4.972 | 2.207 | 225% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.69B | 141B | 2% |
| Annual Yield % from dividends | 0.65 | 2.43 | 27% |
| Returns for 1 year | 9.73 | 4.75 | 205% |
| Returns for 3 years | 31.94 | 14.97 | 213% |
| Returns for 5 years | 22.20 | -7.66 | -290% |
| Returns for 10 years | N/A | 41.85 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DMO | 10.66 | 0.02 | +0.19% |
| Western Asset Mortgage Opportunity Fund | |||
| SNAG | 4.45 | N/A | N/A |
| Leverage Shares 2X Long SNAP Daily ETF | |||
| IWN | 219.78 | -0.19 | -0.09% |
| iShares Russell 2000 Value ETF | |||
| FAX | 14.53 | -0.15 | -1.02% |
| abrdn Asia-Pacific Income Fund | |||
| IBRN | 38.21 | -0.84 | -2.16% |
| iShares Neuroscience and Healthcare ETF | |||